September 30, 2016 1:56 PM ET

Pharmaceuticals

Company Overview of Sequus Pharmaceuticals, Inc.

Key Executives for Sequus Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Kenneth D. Cunningham M.D.No RelationshipsVice President of Clinical Development and Medical Director67

Sequus Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
E. Donnall Thomas M.D. 1 RelationshipsSequus Pharmaceuticals, Inc.95
Robin D. Campbell Ph.D. 6 RelationshipsPfenex Inc.61
View All Board Members

Sequus Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
404.5K
Bonus
508.6K
Total Short Term Compensation
593.3K
Total Value of Options
14.2M
Compensation as of Fiscal Year
Sequus Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Glaxosmithkline Promotes Brian Mcnamara to Lead the Pharmaceuticals's Consumer Healthcare Division
September 30, 2016 5:45 AM ET
Crescita Therapeutics Inc. Announces Board Changes
September 29, 2016 9:00 PM ET
True Nature Holding, Inc. Announces Management Changes
September 29, 2016 11:26 AM ET
Abbott India Appoints Ambati Venu as Additional Director on the Board and as Managing Director
September 29, 2016 10:30 AM ET
Stada-Arzneimittel AG Announces Executive Changes
September 29, 2016 10:30 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Sequus Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.